Philipp Müller

发表

Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activity

P. Herzig, A. Zippelius, R. Zeidler, 2015, Journal of enzyme inhibition and medicinal chemistry.

Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy

M. Löhning, F. Kreppel, D. Merkler, 2017, Nature Communications.

Combining ADCs with Immuno-Oncology Agents

Jay Harper, J. Rios-Doria, Anthony T. Cao, 2018 .

Evaluating Antibody Pharmacokinetics as Prerequisite for Determining True Efficacy as Shown by Dual Targeting of PD-1 and CD96

P. Maier, Wolfgang Rist, M. Reschke, 2022, Biomedicines.

Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity

S. Theurich, M. von Bergwelt-Baildon, A. Zippelius, 2014, Oncoimmunology.

The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models

A. Zippelius, H. Läubli, Abhishek S. Kashyap, 2018, Cancer Immunology, Immunotherapy.

Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade

N. Harbeck, O. Gluz, S. Reddy, 2015, Science Translational Medicine.

The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity

D. Lardinois, D. Thommen, A. Zippelius, 2014, Cancer Immunology, Immunotherapy.

Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptor

C. Klein, M. Bacac, P. Pisa, 2016, Oncoimmunology.

Induced PD-L1 Expression Mediates Acquired Resistance to Agonistic Anti-CD40 Treatment

P. Herzig, A. Zippelius, J. Schreiner, 2015, Cancer Immunology Research.

A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer

A. Yermanos, S. Reddy, M. Prummer, 2019, Journal of Immunotherapy for Cancer.

Cancer immunology - development of novel anti-cancer therapies.

S. Rothschild, D. Thommen, A. Zippelius, 2015, Swiss medical weekly.

T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis

R. Flavell, M. Soengas, H. Anders, 2023, Immunity.

Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors

Jens Schreiner, Anton Belousov, Didier Lardinois, 2015, Cancer Immunology Research.

Microtubule-Depolymerizing Agents Used in Antibody–Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells

D. Speiser, S. Dirnhofer, S. Theurich, 2014, Cancer Immunology Research.

Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells

L. Bubendorf, S. Rothschild, A. Zippelius, 2015, Cancer Immunology, Immunotherapy.